share_log

Khiron Life Sciences Corp. (OTCMKTS:KHRNF) Short Interest Up 55.1% in August

Khiron Life Sciences Corp. (OTCMKTS:KHRNF) Short Interest Up 55.1% in August

契龍生命科學公司(OTCMKTS：KHRNF)空頭股數8月份上漲55.1%
Defense World ·  2022/09/16 02:11

Khiron Life Sciences Corp. (OTCMKTS:KHRNF – Get Rating) was the target of a large growth in short interest in August. As of August 31st, there was short interest totalling 150,800 shares, a growth of 55.1% from the August 15th total of 97,200 shares. Based on an average daily volume of 219,300 shares, the days-to-cover ratio is currently 0.7 days.

凱龍生命科學股份有限公司是8月份空頭股數大幅增長的目標。截至8月31日，空頭股數共有150,800股，比8月15日的97,200股增長了55.1%。以日均成交量21.93萬股計算，目前天數與回補比率為0.7天。

Khiron Life Sciences Stock Performance

科龍生命科學的股票表現

OTCMKTS KHRNF opened at $0.09 on Friday. The company has a fifty day moving average price of $0.10 and a 200-day moving average price of $0.13. Khiron Life Sciences has a 1 year low of $0.08 and a 1 year high of $0.24.

OTCMKTS KHRNF上週五開盤報0.09美元。該公司的50日移動均線價格為0.10美元，200日移動均線價格為0.13美元。凱龍生命科學的一年低點為0.08美元，一年高位為0.24美元。

Get
到達
Khiron Life Sciences
科隆生命科學
alerts:
警報：

Khiron Life Sciences Company Profile

凱龍生命科學公司簡介

(Get Rating)

(獲取評級)

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis.
Khron生命科學公司在拉丁美洲和歐洲作為一家綜合醫療和大麻公司運營。它通過健康服務、醫用大麻產品和健康產品細分市場進行運營。該公司專注於四氫大麻酚和大麻二醇(CBD)醫用大麻的種植、生產、分銷和出口。

Featured Stories

專題報道

  • Get a free copy of the StockNews.com research report on Khiron Life Sciences (KHRNF)
  • Is There a Cure for What is Ailing Teladoc Stock?
  • No One Told These 3 Stocks It's a Down Week
  • Why Medical Products Maker Repligen May Be A Potential Buy
  • At 10%, Is Arbor Realty Trust Dividend Worth It?
  • Investors Should Tune Into RF Industries
  • 免費獲取StockNews.com關於Khron生命科學(KHRNF)的研究報告
  • 有什麼辦法可以治癒Teladoc股票的問題嗎？
  • 沒有人告訴這三隻股票這是下跌的一週
  • 為什麼醫療產品製造商Repligen可能成為潛在收購對象
  • 在10%的水平上，Arbor Realty Trust的股息值得嗎？
  • 投資者應關注RF Industries

Receive News & Ratings for Khiron Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Khiron Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

接受《凱龍生命科學日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Khron生命科學和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論